TIL FY 2021 Earnings — Instil Bio, Inc. Revenue & Financial Results | Market Cap Arena

TILInstil Bio, Inc.

$60M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0-100.0% YoY

Gross Profit

$0

Operating Income

-$156M

Net Income

-$157M

EPS (Diluted)

$-29.60

Cash Flow

Operating Cash Flow

-$122M

Free Cash Flow

-$180M

Stock-Based Comp.

$26M

Balance Sheet

Total Assets

$610M

Total Liabilities

$55M

Stockholders' Equity

$555M

Cash & Equivalents

$38M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$138,000	-100.0%
Gross Profit	$0	$138,000	-100.0%
Operating Income	-$156M	-$34M	-362.4%
Net Income	-$157M	-$38M	-315.5%